In a recent study, it has been demonstrated that tyrosine kinase inhibitor (TKI) resistance in non-small cell lung cancer (NSCLC) could be caused by mutated epidermal growth factor receptor (EGFR) which uses the regulation of the fatty acid synthase (FASN) to induce TKI [134]. Here, EGFR is linked to non-small cell lung carcinoma.